Alere

/Tag:Alere
16 01, 2017

Important Factors and Trends Driving the Blood Gas and Electrolyte Analyzer Market

By |January 16th, 2017|Blood Gas Analyzers, Electrolyte Analyzers|Comments Off on Important Factors and Trends Driving the Blood Gas and Electrolyte Analyzer Market

The introduction of portable blood gas and electrolyte analyzers is one of the more recent developments in the medical lab equipment industry. With advancements in technology, blood gas analyzers have become smarter and enable patient record management more easily. According to Transparency Market Research, the global blood gas and electrolyte analyzer market is expected to [...]

12 02, 2016

Abbott Acquires Alere to Gain Leadership in Point-of-care Segment

By |February 12th, 2016|Abbott Laboratories, Alere|Comments Off on Abbott Acquires Alere to Gain Leadership in Point-of-care Segment

Abbott Laboratories has reached an agreement to acquire Alere Inc for $5.8 billion. In a press release, Abbott said that once the transaction is completed, it will become the leading diagnostics provider of point of care testing. Alere's complementary technologies will help Abbott provide better care for patients by meeting the growing demand for fast, [...]

9 10, 2015

Alere Expands Support to OAFLA in the Fight against HIV

By |October 9th, 2015|Alere, HIV|Comments Off on Alere Expands Support to OAFLA in the Fight against HIV

Global diagnostic device and service provider Alere recently reiterated its commitment to support the Organization of African First Ladies against HIV/AIDS (OAFLA) in the fight against HIV. OAFLA is an alliance of African First Ladies that was established to check HIV transmission. It is a collective voice for Africa’s most vulnerable people, women and children [...]

10 04, 2015

Alere Inc. Gets FDA Approval for i Strep A Test

By |April 10th, 2015|Alere, Triage BNP Test|Comments Off on Alere Inc. Gets FDA Approval for i Strep A Test

Alere Inc., a leader in rapid point of care diagnostics market recently announced that its i Strep A test has won FDA (Food and Drug Administration) 510(K) clearance. Alere’s i Strep A test is the first molecular test that detects group A streptococcus (GAS) bacteria in throat swab specimens in 8 minutes or less. This [...]

6 04, 2015

April is National STD Awareness Month

By |April 6th, 2015|HIV Testing, Siemens Healthcare Diagnostics|Comments Off on April is National STD Awareness Month

April is STD (sexually transmitted diseases) awareness month. STDs are a major public health issue in the United States. This month-long observance is an opportunity to raise public awareness about the impact of STDs and the importance of preventing, testing, and treating STDs. HIV/AIDS, chlamydia, herpes and gonorrhoea are the most common STDs. The Centers [...]

16 02, 2015

Study: Global Cancer Biomarkers Market to Grow at CAGR of 18.26% During 2014-19

By |February 16th, 2015|Abbott Laboratories, Beckman Coulter|Comments Off on Study: Global Cancer Biomarkers Market to Grow at CAGR of 18.26% During 2014-19

With the increased prevalence of cancer, the tools to detect this deadly disease are also in great demand. Cancer biomarkers are molecules secreted by a tumor or a specific response of the body to the presence of cancer. They are non-invasive, enable high speed cancer diagnosis and also enhance early cancer detection and screening. PSA [...]

9 01, 2015

FDA Grants CLIA Waiver for HIV Combo Test

By |January 9th, 2015|Alere, HIV Combo Test|Comments Off on FDA Grants CLIA Waiver for HIV Combo Test

According to the Centers for Disease Control and Prevention (CDC), there are approximately 1.1 million Americans living with HIV. The U.S. Food and Drug Administration (FDA) has recently granted a Clinical Laboratory Improvement Amendments (CLIA) Waiver for the Alere Determine HIV-1/2 Ag/Ab Combo test. The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory [...]

31 10, 2014

Optum Buying Alere Health for $600 Million

By |October 31st, 2014|Alere, Infectious Diseases|Comments Off on Optum Buying Alere Health for $600 Million

With dynamic shifts in the market, there has been a surge in integrated healthcare models. Optum, a unit of Minnesota-based UnitedHealth Group Inc., has made headlines with its decision to buy Alera Health in a $600 million all-cash transaction. Alere Health is a division of Alere Inc., a provider of rapid diagnostics for infectious disease, [...]

4 10, 2014

Importance of HIV and HCV Testing During Pregnancy

By |October 4th, 2014|Abbott Laboratories|Comments Off on Importance of HIV and HCV Testing During Pregnancy

Vertical transmission is becoming the leading source of infection for those individuals, especially pregnant women who have never been tested for the presence of human immunodeficiency virus (HIV) or hepatitis C virus (HCV) in their blood. According to CDC, almost one in six (15.8%) people in the U.S with this disease are unaware of their [...]

25 09, 2014

Growing Importance of Diagnosis at the Point of Care

By |September 25th, 2014|Abbott Laboratories, Point of Care Analyzers|Comments Off on Growing Importance of Diagnosis at the Point of Care

The development of portable diagnostic point of care analyzers and other monitoring devices has resulted in timely, rapid treatment to the patient. These self-contained devices allow diagnoses to be made in the physician's office, the home, an ambulance, in the hospital, and other settings. Patients no longer have to wait hours or even days for [...]